Unknown PHASE1 INTERVENTIONAL 1-arm NCT01220284

Satraplatin and Vinorelbine in Advanced Solid Tumors

Dose-finding Study of Satraplatin in Combination With Oral Vinorelbine in Patients With Advanced Solid Tumors

Sponsor: Agennix

Interventions Satraplatin in combo with vinorelbine

Updated 4 times since 2017 Last updated: Oct 11, 2010 Started: Feb 29, 2008 Primary completion: Nov 30, 2010 Completion: Feb 28, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Advanced Solid Tumors, this trial is ongoing. The trial is conducted by Agennix and has accumulated 4 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE1

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Agennix
Pierre Fabre Laboratories
Southern Europe New Drug Organization

Data source: Southern Europe New Drug Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bellinzona, Switzerland
• Chur, Switzerland